Ultra Clean Reports First Quarter 2025 Financial Results
HAYWARD, Calif., April 28, 2025 /PRNewswire/ — Ultra Clean Holdings, Inc. (Nasdaq: UCTT), today reported its financial results for the first quarter ended... Read more.
Stubbs Alderton & Markiles Announces Closing of its Preccelerator® Program
SANTA MONICA, Calif., April 28, 2025 /PRNewswire/ — Stubbs Alderton & Markiles, LLP (SA&M), one of Southern California’s leading business... Read more.
AMGEN ANNOUNCES WEBCAST OF 2025 FIRST QUARTER FINANCIAL RESULTS
THOUSAND OAKS, Calif., April 28, 2025 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that it will report its first quarter 2025 financial results on Thursday,... Read more.
Sanmina Reports Second Quarter Fiscal 2025 Financial Results
SAN JOSE, Calif., April 28, 2025 /PRNewswire/ — Sanmina Corporation (“Sanmina” or the “Company”) (NASDAQ: SANM), a leading integrated... Read more.
Matson Announces Leadership Succession Plan for Logistics Unit
HONOLULU, April 28, 2025 /PRNewswire/ — Matson, Inc. (“Matson” or the “Company”) (NYSE: MATX) announced today that Rusty Rolfe, Executive... Read more.
Sun Life U.S. expands Family Leave Insurance to Arizona, Wyoming and Pennsylvania
WELLESLEY, Mass., April 28, 2025 /PRNewswire/ — Sun Life U.S. has expanded the availability of its Family Leave Insurance (FLI) offering to now include Arizona,... Read more.
Privo Technologies Expands CLN-004 Clinical Trial Across Leading U.S. Cancer Centers
PEABODY, Mass., April 28, 2025 /PRNewswire/ — Privo Technologies, Inc., a clinical-stage biopharmaceutical company pioneering nanotechnology-based cancer therapies,... Read more.
AI, Compliance, and Modernization Top Priorities for Healthcare IT Leaders in 2025, According to Info-Tech Research Group’s New Report
A new report from global research and advisory firm Info-Tech Research Group highlights the top six strategic healthcare industry topics for 2025 that IT leaders... Read more.
Sudokoo Unleashes a New Era of CPU Cooling for PC Gamers and System Builders
Introducing the SK700, PROTEUS, and NEXAURA Series — Cooling Systems Engineered for Maximum Performance and Eye-Catching Style LOS ANGELES, April 28, 2025 /PRNewswire/... Read more.
Accent Therapeutics Presents Data Supporting Therapeutic Potential of First-in-Class DHX9 Inhibitor, ATX-559, and Novel KIF18A Inhibitor, ATX-295, at the AACR Annual Meeting 2025
ATX-559, a first-in-class oral DHX9 inhibitor, shown to induce potent and selective tumor growth inhibition in preclinical models of cancers with high genomic instability... Read more.